{"paper_id":"228c2f06-9e85-47fe-9995-d681f7ee2cb1","body_text":"ABSTRACT\nThe public health impact of vaping in the United States reflects a complex balance of potential benefits and emerging risks. While e-cigarettes can substantially reduce exposure to toxic combustion byproducts and may aid in smoking cessation for adult tobacco users, evidence links e-cigarette use to respiratory and cardiovascular injury, raising concerns about long-term health outcomes in vapers. Unfortunately, vaping has become deeply entrenched among youth. In 2024, 38.4% of adolescent e-cigarette users reported habitual vaping patterns, underscoring persistent nicotine dependence within this vulnerable population. This escalating youth uptake underscores the urgent need for comprehensive, evidence-based policies that simultaneously advance cessation support for adults and enable robust prevention strategies for adolescents. Thus, to inform the optimal use of predictive technologies in vaping cessation efforts, we conducted a social-media–based survey targeting young adult vapers. Our aims were to (1) characterize cessation-related behaviors and attitudes and (2) evaluate machine learning and XAI methods for predicting quit attempts and successes within this population In our study, we employed both forward selection and backward elimination techniques to identify key predictors of successful vaping cessation. The dataset was partitioned into training (70%) and testing (30%) subsets to facilitate model development and evaluation. We applied a range of machine learning algorithms to the training data and subsequently validated their performance on the test set. For linear modeling, we utilized least absolute shrinkage and selection operator (LASSO), ridge regression, and elastic net. In addition, we incorporated non-linear approaches including random forest (RF) and support vector machine (SVM) to capture more complex relationships within the data. We assessed the model performance through C-Statistics/ area under the curve (AUC). Further we validated the performance through Brier Scores. Among the models evaluated, linear approaches demonstrated superior overall performance, with non-linear models such as random forest (RF) and support vector machine (SVM) exhibiting strong predictive accuracy on the training data. LASSO regression yielded robust results, with area under the curve (AUC) values of 0.89 for the training set and 0.91 for the test set. Ridge regression followed closely, achieving AUCs of 0.88 and 0.93, respectively. Elastic net regression performed consistently across both datasets, with an AUC of 0.91 in training and testing.\nKey predictors of successful vaping cessation included age, environmental triggers, vaping frequency, sex, and long-term behavioral outlook. Age emerged as a particularly influential factor, with individuals under 25 exhibiting increased vulnerability—likely due to neurodevelopmental sensitivity and elevated usage rates. Environmental cues, especially social exposure, were strongly associated with relapse risk, highlighting the importance of trigger management in cessation strategies. Interestingly, vaping frequency served as a counterintuitive indicator: erratic usage patterns correlated with lower cessation success, suggesting that consistent use may reflect a greater readiness for behavioral change. Sex-based differences were also notable, with males demonstrating more intense withdrawal symptoms and higher consumption levels, underscoring the need for gender-responsive interventions.\nThese findings underscore the utility of machine learning in uncovering nuanced behavioral and contextual determinants of addiction and cessation outcomes, offering valuable insights for the design of targeted public health interventions.\nCompeting Interest Statement\nThe authors have declared no competing interest.\nFunding Statement\nThe author(s) received no specific funding for this work.\nAuthor Declarations\nI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.\nNot Applicable\nThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:\nThis study was approved by our institution's UBIRB. IRB ID # STUDY00005954 UBIRB determined on 1/27/2022 that the research is Exempt according to 45 CFR Part 46.104. There is no expiration date.\nI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.\nNot Applicable\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\nNot Applicable\nI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.\nNot Applicable\nData Availability\nData will be available on request","source_license":"CC-BY-4.0","license_restricted":false}